Association of cutaneous melanoma with risk of subsequent non-cutaneous malignancies

Nowadays, the 5-year relative survival rate for melanoma is over 60%. Concerns regarding second primary malignancies (SPM) have emerged during follow-up. The aim of this meta-analysis is to investigate site-specific risks of subsequent non-cutaneous malignancies in melanoma survivors. Supplemental files for this meta-analysis were attached.

当前，黑色素瘤（melanoma）的5年相对生存率已超过60%。在随访过程中，关于黑色素瘤幸存者发生第二原发恶性肿瘤（second primary malignancies, SPM）的相关问题逐渐受到关注。本项荟萃分析（meta-analysis）旨在探究黑色素瘤幸存者后续发生非皮肤恶性肿瘤的部位特异性风险。本项荟萃分析的补充材料已随文附上。